Amalgamated Bank’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.37M Buy
11,118
+1,018
+10% +$270K 0.04% 414
2026
Q1
$1.11M Sell
10,100
-535
-5% -$76.2K 0.01% 1024
2025
Q4
$1.77M Buy
10,635
+476
+5% +$79.6K 0.01% 866
2025
Q3
$1.99M Sell
10,159
-613
-6% -$101K 0.01% 823
2025
Q2
$974K Buy
10,772
+4,848
+82% +$383K 0.01% 1050
2025
Q1
$353K Buy
5,924
+33
+0.6% +$3.05K ﹤0.01% 1375
2024
Q4
$780K Buy
5,891
+4,670
+382% +$438K 0.01% 1140
2024
Q3
$64K Hold
1,221
﹤0.01% 1786
2024
Q2
$74K Buy
+1,221
New +$84.7K ﹤0.01% 1778

Other funds holding ALAB

Amalgamated Bank's ALAB Position: Q2 2026 in Review

Amalgamated Bank increased its Astera Labs (ALAB) stake by 10% in Q2 2026, buying an estimated $270K and bringing the position to 11,118 shares worth $5.37M. The position accounts for 0.04% of the portfolio, ranked #414.

Amalgamated Bank first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Amalgamated Bank held 11,118 shares of Astera Labs worth $5.37M as of Q2 2026.
  • Amalgamated Bank bought 1,018 Astera Labs shares in Q2 2026, an estimated $270K.
  • Astera Labs made up 0.04% of Amalgamated Bank's portfolio in Q2 2026, its #414 holding.
  • Amalgamated Bank first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.